PDF herunterladen
Am J Perinatol 2021; 38(S 01): e173-e181
DOI: 10.1055/s-0040-1708855
Original Article

Maternal Metabolic Biomarkers are Associated with Obesity and Excess Gestational Weight Gain

Kathleen M. Antony 
1   Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas
2   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas
3   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Wisconsin-Madison, Madison, Wisconsin
,
Mona Romezi
1   Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas
,
Kourtnee Lindgren
1   Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas
,
Kristen B. Mitchell
1   Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas
,
Susan F. Venable
4   Department of Immunology and Pathology, Baylor College of Medicine, Houston, Texas
,
Diana A. Racusin
1   Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas
2   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas
5   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Texas Health Science Center at Houston, Houston, Texas
,
Melissa A. Suter
1   Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas
,
Kjersti M. Aagaard
1   Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas
2   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas
› Institutsangaben Funding This study received funding from Baylor College of Medicine, Department of Obstetrics and Gynecology Resident Research Grant 2012–2013 (M.R.).
› Weitere Informationen
    Lizenzen und Reprints

Abstract

Objective The purpose of this study was to evaluate the independent contribution of maternal obesity and gestational weight gain (GWG) in excess of the Institute of Medicine's guidelines on levels of maternal serum inflammatory and metabolic measures.

Study Design Banked maternal serum samples from 120 subjects with documented prepregnancy or first trimester body mass index (BMI) were utilized for analyte analyses. Validated, BMI-specific formulas were utilized to categorize GWG as either insufficient, at goal or excess based on the Institute of Medicine guidelines with gestational age adjustments. Serum was analyzed for known inflammatory or metabolic pathway intermediates using the Luminex xMap system with the MILLIPLEX Human Metabolic Hormone Magnetic Bead Panel. Measured analytes included interleukin-6, monocyte chemoattractant protein-1, and tumor necrosis factor-α and metabolic markers amylin, c-peptide, ghrelin, gastric inhibitory polypeptide, glucagon-like peptide-1, glucagon, insulin, leptin, pancreatic polypeptide, and peptide YY. Kruskal–Wallis ANOVA and Pearson's correlation coefficients were calculated for each marker.

Results C-peptide, insulin, and leptin all varied significantly with both obesity and GWG while glucagon-like peptide-1 varied by BMI but not GWG. These analytes covaried with other metabolic analytes, but not with inflammatory analytes.

Conclusion Maternal metabolic biomarkers at delivery vary significantly with both obesity and GWG. Taken together, these findings suggest that GWG (with and without comorbid obesity) is an important mediator of measurable metabolites in pregnancy but is not necessarily accompanied by inflammatory measures in serum. These findings are consistent with GWG being an independent risk factor for metabolic disturbances during pregnancy.

Keywords

pregnancy - obesity - gestational weight gain - metabolic markers - inflammatory markers

Note

Data from this article were presented as a poster presentation at the Society for Maternal-Fetal Medicine's 34th Annual Meeting—The Pregnancy Meeting, New Orleans, LA, February 3–8, 2014, Abstract Number 669 and at the Society for Maternal-Fetal Medicine's 39th Annual Meeting–The Pregnancy Meeting, Las Vegas, NV, February 10–16, 2019, Abstract Number 571.


Supplementary Material



Publikationsverlauf

Eingereicht: 13. September 2019

Angenommen: 20. Februar 2020

Artikel online veröffentlicht:
31. März 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Catalano PM, Shankar K. Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child. BMJ 2017; 356: j1
    CrossrefPubMedGoogle Scholar
  • 2 Gotsch F, Gotsch F, Romero R. et al. The preterm parturition syndrome and its implications for understanding the biology, risk assessment, diagnosis, treatment and prevention of preterm birth. J Matern Fetal Neonatal Med 2009; 22 (May, Suppl 2): 5-23
    CrossrefPubMedGoogle Scholar
  • 3 Amaral LM, Wallace K, Owens M, LaMarca B. Pathophysiology and current clinical management of preeclampsia. Curr Hypertens Rep 2017; 19 (08) 61
    CrossrefPubMedGoogle Scholar
  • 4 Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 1993; 259 (5091): 87-91
    CrossrefPubMedGoogle Scholar
  • 5 Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001; 280 (05) E745-E751
    CrossrefPubMedGoogle Scholar
  • 6 Kirwan JP, Hauguel-De Mouzon S, Lepercq J. et al. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 2002; 51 (07) 2207-2213
    CrossrefPubMedGoogle Scholar
  • 7 Zhang H, Zhang C. Regulation of microvascular function by adipose tissue in obesity and type 2 diabetes: evidence of an adipose-vascular loop. Am J Biomed Sci 2009; 1 (02) 133
    CrossrefPubMedGoogle Scholar
  • 8 Lago F, Dieguez C, Gómez-Reino J, Gualillo O. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev 2007; 18 (3-4): 313-325
    CrossrefPubMedGoogle Scholar
  • 9 Challier JC, Basu S, Bintein T. et al. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta 2008; 29 (03) 274-281
    CrossrefPubMedGoogle Scholar
  • 10 Hauguel-de Mouzon S, Guerre-Millo M. The placenta cytokine network and inflammatory signals. Placenta 2006; 27 (08) 794-798
    CrossrefPubMedGoogle Scholar
  • 11 Stewart FM, Freeman DJ, Ramsay JE, Greer IA, Caslake M, Ferrell WR. Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers. J Clin Endocrinol Metab 2007; 92 (03) 969-975
    CrossrefPubMedGoogle Scholar
  • 12 Fantuzzi G, Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 2000; 68 (04) 437-446
    CrossrefPubMedGoogle Scholar
  • 13 Lappas M, Permezel M, Rice GE. Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-kappaB, peroxisomal proliferator-activated receptor-γ and extracellularly regulated kinase 1/2. Endocrinology 2005; 146 (08) 3334-3342
    CrossrefPubMedGoogle Scholar
  • 14 Do Carmo S, Forest J-C, Giguère Y, Masse A, Lafond J, Rassart E. Modulation of apolipoprotein D levels in human pregnancy and association with gestational weight gain. Reprod Biol Endocrinol 2009; 7: 92
    CrossrefPubMedGoogle Scholar
  • 15 Antony KM, Hemarajata P, Chen J. et al. Generation and validation of a universal perinatal database and biospecimen repository: PeriBank. J Perinatol 2016; 36 (11) 921-92
    CrossrefPubMedGoogle Scholar
  • 16 Johnson J, Clifton RG, Roberts JM. et al; Eunice Kennedy Shriver National Institute of Child Health; Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Pregnancy outcomes with weight gain above or below the 2009 Institute of Medicine guidelines. Obstet Gynecol 2013; 121 (05) 969-975
    CrossrefPubMedGoogle Scholar
  • 17 Committee to Reexamine IOM Pregnancy Weight Guidelines, Institute of Medicine, National Research Council. Rasmussen KM, Yaktine AL, eds. Weight Gain During Pregnancy: Reexamining the Guidelines. WA, USA: The National Academies Press; 2009
  • 18 Antony KM, Ma J, Mitchell KB, Racusin DA, Versalovic J, Aagaard K. The preterm placental microbiome varies in association with excess maternal gestational weight gain. Am J Obstet Gynecol 2015; 212 (05) 653.e1-653.e16
    CrossrefPubMedGoogle Scholar
  • 19 EMD Millipore Corporation.. Human Metabolic Hormone Magnetic Bead Panel 96-Well Plate Assay Cat. #HMHEMAG-34K. Billerica, MA. Accessed March 5, 2020 at: http://www.emdmillipore.com/US/en/product/MILLIPLEX-MAP-Human-Metabolic-Hormone-Magnetic-Bead-Panel-Metabolism-Multiplex-Assay,MM_NF-HMHEMAG-34K#anchor_PR
    PubMedGoogle Scholar
  • 20 Westermeier F, Sáez PJ, Villalobos-Labra R, Sobrevia L, Farías-Jofré M. Programming of fetal insulin resistance in pregnancies with maternal obesity by ER stress and inflammation. BioMed Res Int 2014; 2014 (917672): 917672
    CrossrefPubMedGoogle Scholar
  • 21 Berglund SK, García-Valdés L, Torres-Espinola FJ. et al; PREOBE team. Maternal, fetal and perinatal alterations associated with obesity, overweight and gestational diabetes: an observational cohort study (PREOBE). BMC Public Health 2016; 16 (01) 207
    CrossrefPubMedGoogle Scholar
  • 22 Perichart-Perera O, Muñoz-Manrique C, Reyes-López A, Tolentino-Dolores M, Espino Y Sosa S, Ramírez-González MC. Metabolic markers during pregnancy and their association with maternal and newborn weight status. PLoS One 2017; 12 (07) e0180874
    CrossrefPubMedGoogle Scholar
  • 23 Ramsay JE, Ferrell WR, Crawford L, Wallace AM, Greer IA, Sattar N. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab 2002; 87 (09) 4231-4237
    CrossrefPubMedGoogle Scholar
  • 24 Solis-Paredes M, Estrada-Gutierrez G, Perichart-Perera O. et al. Key clinical factors predicting adipokine and oxidative stress marker concentrations among normal, overweight and obese pregnant women using artificial neural networks. Int J Mol Sci 2017; 19 (01) 1-17
    CrossrefPubMedGoogle Scholar
  • 25 Verhaeghe J, van Bree R, Van Herck E. Maternal body size and birth weight: can insulin or adipokines do better?. Metabolism 2006; 55 (03) 339-344
    CrossrefPubMedGoogle Scholar
  • 26 Vernini JM, Moreli JB, Costa RA, Negrato CA, Rudge MV, Calderon IM. Maternal adipokines and insulin as biomarkers of pregnancies complicated by overweight and obesity. Diabetol Metab Syndr 2016; 8 (01) 68
    CrossrefPubMedGoogle Scholar
  • 27 Patenaude J, Lacerte G, Lacroix M. et al. Associations of maternal leptin with neonatal adiposity differ according to pregravid weight. Neonatology 2017; 111 (04) 344-352
    CrossrefPubMedGoogle Scholar
  • 28 Sámano R, Martínez-Rojano H, Chico-Barba G. et al. Serum concentration of leptin in pregnant adolescents correlated with gestational weight gain, postpartum weight retention and newborn weight/length. Nutrients 2017; 9 (10) 1-16
    CrossrefPubMedGoogle Scholar
  • 29 Xargay-Torrent S, Carreras-Badosa G, Borrat-Padrosa S. et al. Circulating sex hormone binding globulin: an integrating biomarker for an adverse cardio-metabolic profile in obese pregnant women. PLoS One 2018; 13 (10) e0205592
    CrossrefPubMedGoogle Scholar
  • 30 Yang X, Li M, Haghiac M, Catalano PM, O'Tierney-Ginn P, Hauguel-de Mouzon S. Causal relationship between obesity-related traits and TLR4-driven responses at the maternal-fetal interface. Diabetologia 2016; 59 (11) 2459-2466
    CrossrefPubMedGoogle Scholar
  • 31 Carreras-Badosa G, Bonmatí A, Ortega FJ. et al. Altered circulating miRNA expression profile in pregestational and gestational obesity. J Clin Endocrinol Metab 2015; 100 (11) E1446-E1456
    CrossrefPubMedGoogle Scholar
  • 32 Stewart F, Rodie VA, Ramsay JE, Greer IA, Freeman DJ, Meyer BJ. Longitudinal assessment of erythrocyte fatty acid composition throughout pregnancy and post partum. Lipids 2007; 42 (04) 335-344
    CrossrefPubMedGoogle Scholar
  • 33 Benaim C, Freitas-Vilela AA, Pinto TJP. et al. Early pregnancy body mass index modifies the association of prepregnancy dietary patterns with serum polyunsaturated fatty acid concentrations throughout pregnancy in Brazilian women. Matern Child Nutr 2018;14(01). doi: 10.1111/mcn.12480
    PubMedGoogle Scholar
  • 34 Vidakovic AJ, Jaddoe VWV, Gishti O. et al. Body mass index, gestational weight gain and fatty acid concentrations during pregnancy: the Generation R Study. Eur J Epidemiol 2015; 30 (11) 1175-1185
    CrossrefPubMedGoogle Scholar
  • 35 Cinelli G, Fabrizi M, Ravà L. et al. Influence of maternal obesity and gestational weight gain on maternal and foetal lipid profile. Nutrients 2016; 8 (06) 1-13
    CrossrefPubMedGoogle Scholar
  • 36 Hrolfsdottir L, Schalkwijk CG, Birgisdottir BE. et al. Maternal diet, gestational weight gain, and inflammatory markers during pregnancy. Obesity (Silver Spring) 2016; 24 (10) 2133-2139
    CrossrefPubMedGoogle Scholar
  • 37 Martins MC, Trujillo J, Farias DR, Kac G. Polymorphisms in the leptin (rs7799039) gene are associated with an increased risk of excessive gestational weight gain but not with leptin concentration during pregnancy. Nutr Res 2017; 47: 53-62
    CrossrefPubMedGoogle Scholar
  • 38 Perng W, Rifas-Shiman SL, Rich-Edwards JW, Stuebe AM, Oken E. Inflammation and weight gain in reproductive-aged women. Ann Hum Biol 2016; 43 (01) 91-95
    CrossrefPubMedGoogle Scholar
  • 39 Considine RV, Sinha MK, Heiman ML. et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334 (05) 292-295
    CrossrefPubMedGoogle Scholar
  • 40 Berggren EK, Groh-Wargo S, Presley L, Hauguel-De Mouzon S, Catalano PM. Maternal fat, but not lean, mass is increased among overweight/obese women with excess gestational weight gain Presented in poster format at the 75th Scientific Sessions of the American Diabetes Association, Boston, MA, June 5–9, 2015. Am J Obstet Gynecol 2016; 214 (06) 745.e1-745.e5
    CrossrefPubMedGoogle Scholar
  • 41 Ehrenberg HM, Huston-Presley L, Catalano PM. The influence of obesity and gestational diabetes mellitus on accretion and the distribution of adipose tissue in pregnancy. Am J Obstet Gynecol 2003; 189 (04) 944-948
    CrossrefPubMedGoogle Scholar
  • 42 Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998; 394 (6696): 897
    CrossrefPubMedGoogle Scholar
  • 43 McDonald SD, Han Z, Mulla S, Beyene J. ; Knowledge Synthesis Group. Overweight and obesity in mothers and risk of preterm birth and low birth weight infants: systematic review and meta-analyses. BMJ 2010; 341 (c3428): c3428
    CrossrefPubMedGoogle Scholar
  • 44 Russell A, Gillespie S, Satya S, Gaudet LM. Assessing the accuracy of pregnant women in recalling prepregnancy weight and gestational weight gain. J Obstet Gynaecol Can 2013; 35 (09) 802-809
    CrossrefPubMedGoogle Scholar
  • 45 Risberg A, Sjöquist M, Wedenberg K, Larsson A. Elevated glucose levels in early puerperium, and association with high cortisol levels during parturition. Scand J Clin Lab Invest 2016; 76 (04) 309-312
    CrossrefPubMedGoogle Scholar
  • 46 Muktabhant B, Lawrie TA, Lumbiganon P, Laopaiboon M. Diet or exercise, or both, for preventing excessive weight gain in pregnancy. Cochrane Database Syst Rev 2015; 6 (06) CD007145
    PubMedGoogle Scholar